Comparison of survival and tumor recurrence rates in patients undergoing liver transplantation for hepatitis B-related hepatocellular carcinoma using Milan, Shanghai Fudan and Hangzhou criteria

Journal of Digestive Diseases

Volumn 14, Issue 10, 2013, Pages 552-558

  Gao, Ting ^a   Xia, Qiang ^a   Qiu, De Kai ^a,b   Feng, Yi Yan ^a,b   Chi, Jia Chang ^a   Wang, Si Yue ^a   Xi, Zhi Feng ^a   Zhang, Jian Jun ^a   Xu, Ning ^a   Chen, Shi Yao ^c   Qiu, Yu Lan ^a   Shen, Li Wei ^a,b   Zhou, Ting Ting ^a,b   Dong, Xiao Jun ^a,b   Li, Qi Gen ^a   Li, Hai ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Hangzhou criteria; Hepatitis B virus; Hepatocellular carcinoma; Liver transplantation; Milan criteria; Shanghai Fudan criteria

Indexed keywords

CISPLATIN; CYCLOSPORIN A; FLUOROURACIL; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; MITOMYCIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NUCLEOSIDE ANALOG; PREDNISONE; TACROLIMUS;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; ASCITES; BONE SCINTISCANNING; BRAIN DISEASE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD TURCOTTE PUGH SCORE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE CLASSIFICATION; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; HANGZHOU CRITERIA; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MILAN, SHANGHAI FUDAN CRITERIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE RISK; REINFECTION; SURVIVAL RATE; THORAX RADIOGRAPHY; TUMOR GROWTH;

HANGZHOU CRITERIA; HEPATITIS B VIRUS; HEPATOCELLULAR CARCINOMA; LIVER TRANSPLANTATION; MILAN CRITERIA; SHANGHAI FUDAN CRITERIA;

ADULT; CARCINOMA, HEPATOCELLULAR; DATABASES, FACTUAL; FEMALE; HEPATITIS B; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84883443690     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12083     Document Type: Article

References (24)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576.
2. Mazzaferro V, Regalia E, Doci R etal. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
3. Decaens T, Roudot-Thoraval F, Hadni-Bresson S etal. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006; 12: 1761-1769.
4. Ito T, Takada Y, Ueda M etal. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007; 13: 1637-1644.
5. Herrero JI, Sangro B, Pardo F etal. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Liver Transpl 2008; 14: 272-278.
6. Audet M, Panaro F, Piardi T, Wolf P. Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries? Liver Transpl 2009; 15: 822-823; author reply 824-6.
7. Yao FY, Ferrell L, Bass NM etal. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403.
8. Duffy JP, Vardanian A, Benjamin E etal. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 2007; 246: 502-11.
9. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
10. Fan J, Zhou J, Xu Y etal. Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan criteria. Natl Med J China 2006; 86: 1227-1231 (in Chinese).
11. Zheng SS, Xu X, Wu J etal. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008; 85: 1726-1732.
12. The Chinese National Workshop on Fatty Liver and Alcoholic Liver Disease for the Chinese Liver Disease Association. Guidelines for management of alcoholic liver disease. Chin J Gastroenterol 2010; 15: 517-521 (in Chinese).
13. Xi ZF, Xia Q, Zhang JJ etal. The role of entecavir in preventing hepatitis B recurrence after liver transplantation. J Dig Dis 2009; 10: 321-327.
14. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N. Cirrhosis or chronic hepatitis: evaluation of small (≤2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 2003; 226: 550-555.
15. Llovet JM, Di Bisceglie AM, Bruix J etal.; Panel of Experts in HCC-Design Clinical Trials. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008; 100: 698-711.
16. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
17. Freeman RB Jr, Wiesner RH, Harper A etal.; UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 851-858.
18. Yao FY. Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transplant 2008; 8: 1982-1989.
19. Silva MF, Wigg AJ. Current controversies surrounding liver transplantation for hepatocellular carcinoma. J Gastroenterol Hepatol 2010; 25: 1217-1226.
20. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25: 181-200.
21. Hwang S, Lee SG, Belghiti J. Liver transplantation for HCC: its role: Eastern and Western perspectives. J Hepatobiliary Pancreat Sci 2010; 17: 443-448.
22. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007; 7: 2587-2596.
23. Cillo U, Vitale A, Bassanello M etal. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 2004; 239: 150-159.
24. Volk ML, Vijan S, Marrero JA. A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant 2008; 8: 839-846.